Eosinophilic inflammation (immune cells usually associated with allergy) can help to inform us about which treatments will work the best in our patients with COPD according to research by Prof Mona Bafadhel, recently published in the Lancet.
Eosinophils in COPD: just another biomarker?
Research
13 July 2017
Chronic obstructive pulmonary disease (COPD) is a common chronic lung disease associated with significant illness.